S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA Price Target, Predictions & Analyst Ratings

$31.52
+0.07 (+0.22%)
(As of 12/8/2021 04:00 PM ET)
Add
Compare
Today's Range
$31.28
$31.62
50-Day Range
$29.82
$36.05
52-Week Range
$29.71
$43.33
Volume
190,404 shs
Average Volume
358,759 shs
Market Capitalization
$18.47 billion
P/E Ratio
16.86
Dividend Yield
1.81%
Beta
1.25

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Hold
Based on 20 Analyst Ratings

Analyst Price Target Consensus

$38.33
21.62% Upside

High PT$40.00
Average PT$38.33
Low PT$35.00
TypeCurrent
12/9/20 to 12/9/21
1 Month Ago
11/9/20 to 11/9/21
3 Months Ago
9/10/20 to 9/10/21
1 Year Ago
12/10/19 to 12/9/20
Consensus Rating
Hold
Hold
Hold
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
10 Buy rating(s)
Hold
14 Hold rating(s)
12 Hold rating(s)
11 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$38.33$40.00N/A$45.13
Price Target Upside21.62% Upside13.81% UpsideN/A13.76% Upside
Get Fresenius Medical Care AG & Co. KGaA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) vs. Its Competitors

TypeFresenius Medical Care AG & Co. KGaAMedical CompaniesS&P 500
Consensus Rating Score
2.20
2.73
2.56
Consensus RatingHoldBuyBuy
Price Target Upside21.62% Upside1,524.61% Upside10.05% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
366
54.38%
Underperform Votes
307
45.62%
Avg. Outperform Votes
177
67.56%
Avg. Underperform Votes
85
32.44%
Avg. Outperform Votes
834
69.44%
Avg. Underperform Votes
367
30.56%

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/1/2021Deutsche Bank Aktiengesellschaft
Reiterated RatingHold
11/23/2021HSBC
Initiated CoverageHold
11/17/2021Royal Bank of Canada
Lower Price TargetSector Perform$42.00 ➝ $35.00+6.90%
11/11/2021Jefferies Financial Group
UpgradeUnderperform ➝ Hold
11/10/2021Berenberg Bank
Reiterated RatingBuy
11/9/2021JPMorgan Chase & Co.
Reiterated RatingUnderweight
10/21/2021Barclays
Hassan Al-Wakeel
Reiterated RatingEqual Weight
10/13/2021Truist Securities
Lower Price TargetHold$44.00 ➝ $40.00+13.73%
8/4/2021Societe Generale
Reiterated RatingHold
7/20/2021UBS Group
Reiterated RatingBuy
5/12/2021Nord/LB
UpgradeHold ➝ Buy
5/11/2021DZ Bank
Reiterated RatingBuy
5/10/2021Credit Suisse Group
Reiterated RatingNeutral
2/4/2021BNP Paribas
DowngradeOutperform ➝ Neutral
2/4/2021Exane BNP Paribas
DowngradeOutperform ➝ Neutral
2/4/2021Kepler Capital Markets
DowngradeBuy ➝ Hold
2/3/2021The Goldman Sachs Group
DowngradeConviction-Buy ➝ Buy
2/1/2021Stifel Nicolaus
DowngradeBuy ➝ Hold
12/9/2020Morgan Stanley
Reiterated RatingEqual Weight
5/21/2020SunTrust Banks
Boost Price TargetBuy$46.00 ➝ $48.00+17.10%
2/21/2020Cfra
UpgradeHold ➝ Buy$38.00 ➝ $46.00+12.28%
10/23/2019Redburn Partners
Reiterated RatingBuy ➝ Neutral
8/1/2019BTIG Research
DowngradeBuy ➝ Neutral
5/9/2019Commerzbank
Reiterated RatingHold$54.00+30.72%
(Data available from 12/9/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Analyst Ratings Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA's consensus rating and price target?

According to the issued ratings of 20 analysts in the last year, the consensus rating for Fresenius Medical Care AG & Co. KGaA stock is Hold based on the current 1 sell rating, 14 hold ratings and 5 buy ratings for FMS. The average twelve-month price target for Fresenius Medical Care AG & Co. KGaA is $38.33 with a high price target of $40.00 and a low price target of $35.00. Learn more on FMS's analyst rating history

Do Wall Street analysts like Fresenius Medical Care AG & Co. KGaA more than its competitors?

Analysts like Fresenius Medical Care AG & Co. KGaA stock less than the stock of other Medical companies. The consensus rating for Fresenius Medical Care AG & Co. KGaA is Hold while the average consensus rating for medical companies is Buy. Learn more on how FMS compares to other companies

Do MarketBeat users like Fresenius Medical Care AG & Co. KGaA more than its competitors?

MarketBeat users like Fresenius Medical Care AG & Co. KGaA stock less than the stock of other Medical companies. 54.38% of MarketBeat users gave Fresenius Medical Care AG & Co. KGaA an outperform vote while medical companies recieve an average of 67.56% outperform votes by MarketBeat users.

Is Fresenius Medical Care AG & Co. KGaA being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Fresenius Medical Care AG & Co. KGaA's stock had 2 downgrades and 1 upgrade by analysts.

Does Fresenius Medical Care AG & Co. KGaA's stock price have much upside?

According to analysts, Fresenius Medical Care AG & Co. KGaA's stock has a predicted upside of 11.62% based on their 12-month price targets.

What analysts cover Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA has been rated by Barclays, Berenberg Bank, Deutsche Bank Aktiengesellschaft, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Royal Bank of Canada, Truist, and Truist Securities in the past 90 days.

This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.